155 related articles for article (PubMed ID: 36051002)
21. Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019.
Howe SJ; Lapidus D; Hull M; Yeaw J; Stevenson T; Sampson JB
Orphanet J Rare Dis; 2022 Feb; 17(1):79. PubMed ID: 35197080
[TBL] [Abstract][Full Text] [Related]
22. Economic impact of applying the AASLD-IDSA simplified treatment algorithm on the real-world management of hepatitis C.
Majethia S; Lee IH; Chastek B; Bunner S; Wolf J; Hsiao A; Mozaffari E
J Manag Care Spec Pharm; 2022 Jan; 28(1):48-57. PubMed ID: 34677088
[No Abstract] [Full Text] [Related]
23. A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy.
Leist TP; Cole M; Verma S; Keenan A; Le HH
Mult Scler Relat Disord; 2023 Oct; 78():104917. PubMed ID: 37597349
[TBL] [Abstract][Full Text] [Related]
24. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
25. Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis.
Bonafede M; Anaissie E; Evans K; Itzler R
BMC Health Serv Res; 2021 Oct; 21(1):1125. PubMed ID: 34666775
[TBL] [Abstract][Full Text] [Related]
26. Total cost of care for castration-resistant prostate cancer in a commercially insured population and a medicare supplemental insured population.
Wu B; Li SS; Song J; Pericone CD; Behl AS; Dawson NA
J Med Econ; 2020 Jan; 23(1):54-63. PubMed ID: 31589086
[No Abstract] [Full Text] [Related]
27. The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States.
Rice JB; White AG; Galebach P; Korenblat KM; Wagh A; Lovelace B; Wan GJ; Jamil K
Curr Med Res Opin; 2017 Aug; 33(8):1473-1480. PubMed ID: 28509578
[TBL] [Abstract][Full Text] [Related]
28. Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States.
Wu N; Yu YF; Chuang CC; Wang R; Benjamin NN; Coultas DB
J Med Econ; 2015 Apr; 18(4):249-57. PubMed ID: 25428658
[TBL] [Abstract][Full Text] [Related]
29. Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorder.
Chitnis A; Wang R; Sun SX; Dixit S; Tawah A; Boulanger L
J Med Econ; 2015; 18(11):863-70. PubMed ID: 26121161
[TBL] [Abstract][Full Text] [Related]
30. The economic burden of psoriasis with high comorbidity among privately insured patients in the United States.
Pilon D; Teeple A; Zhdanava M; Ladouceur M; Ching Cheung H; Muser E; Lefebvre P
J Med Econ; 2019 Feb; 22(2):196-203. PubMed ID: 30523738
[TBL] [Abstract][Full Text] [Related]
31. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
32. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
33. Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States.
Kobayashi M; Garside J; Nguyen J
J Health Econ Outcomes Res; 2023; 10(2):104-110. PubMed ID: 37954059
[No Abstract] [Full Text] [Related]
34. Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States population.
Tkacz JP; Rance K; Waddell D; Aagren M; Hammerby E
Curr Med Res Opin; 2021 Jun; 37(6):957-965. PubMed ID: 33754932
[TBL] [Abstract][Full Text] [Related]
35. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF
Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
[TBL] [Abstract][Full Text] [Related]
36. Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.
Polson M; Lord TC; Evangelatos TM; Lopes M; Santaniello BL
Am J Manag Care; 2017 Nov; 23(16 Suppl):S295-S299. PubMed ID: 29144719
[TBL] [Abstract][Full Text] [Related]
37. Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysis.
Weiss T; Ramey DR; Pham N; Shaikh NF; Tian D; Zhao X; Near AM; Lautsch D; Nathan SD
Pulm Circ; 2024 Apr; 14(2):e12390. PubMed ID: 38903484
[TBL] [Abstract][Full Text] [Related]
38. Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.
Zah V; Pelivanovic J; Tatovic S; Vukicevic D; Imro M; Ruby J; Hurley D
Clinicoecon Outcomes Res; 2020; 12():635-643. PubMed ID: 33177851
[TBL] [Abstract][Full Text] [Related]
39. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines.
Amari DT; Juday T; Frech FH; Wang W; Wu Z; Atkins N; Wickwire EM
BMC Geriatr; 2022 Jun; 22(1):484. PubMed ID: 35658904
[TBL] [Abstract][Full Text] [Related]
40. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
Locklear JC; Alemayehu B; Brody RS; Chavoshi S; Tunceli O; Kern D; Earley WR
Clin Ther; 2013 Dec; 35(12):1923-32. PubMed ID: 24275622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
